The 68 references in paper A. Litvinov S., M. Batyushin M., L. Litvinova I., V. Poganeva N., А. Литвинов С., М. Батюшин М., Л. Литвинова И., В. Поганева Н. (2013) “ПРОБЛЕМЫ БИОСОВМЕСТИМОСТИ ДИАЛИЗНОЙ ТЕРАПИИ // BIOCOMPATIBILITY PROBLEMS OF DIALYSIS THERAPY” / spz:neicon:nefr:y:2013:i:5:p:27-34

1
Antisoner RH. Biomaterials science: an introduction to materials in medicine. CA: Academic Press, San Diego, 2004; 5–69
(check this in PDF content)
2
Brodbeck K, Neubauer M, Schnitzer S, Dietrich R, Hulko M, Krause B. Real-time PCR as a new in vitro biocompatibility method to measure leukocyte response to surface contact in dialysis filter devices. Int J Artif Organs 2013; 36 (4): 240–250
(check this in PDF content)
3
Bruck SD. Biomaterials. Med Dev Art Organs 1973; (1): 65–79Buemi M, Coppolini G, Bolignano D. Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. Ren Fail 2009; (31): 75–80
(check this in PDF content)
4
Caballo C, Palomo M, Cases A, Galán AM, Molina P, Vera M, Bosch X, Escolar G, Diaz-Ricart M. NFκB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 2012; 7 (8): 65–84
(check this in PDF content)
5
Chadi S, Iskandar B, Yorg Al A, Ali N, Marc S, Suzanne El, Sayegh. Relationship between platelet count and hemodialysis membranes. Int J Nephrol Renovasc Dis 2013; (6): 143–147
(check this in PDF content)
6
Chen HA, Wang JJ, Chou CT, et al. Predictors of longterm mortality in patients with and without systemic lupus erythematosus on maintenance dialysis: a comparative study. J Rheumatol 2011; (38): 2390–2394
(check this in PDF content)
7
Davenport A. Pyrexia of unknown origin in a haemodialysis patient. NDT Plus 2008; Vol. 2 (3): 76–89
(check this in PDF content)
8
Prada L, Lee J, Gillespie A, Benjamin J. Thrombocytopenia associated with one type of polysulfone hemodialysis membrane: a report of 5 cases. Am J Kidney Dis 2013 Jan; 61(1): 131–133
(check this in PDF content)
9
Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Am J Kidney Dis 2007; May 49 (5): 642–649
(check this in PDF content)
10
Eds B Ratner, Hiffman AS, Schoen FJ, Lemon JE. Biomaterials science: an introduction to materials in medicine, 2nd ed. CA: Academic Press, San Diego, 2004; 851
(check this in PDF content)
11
Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Biomaterial 2005; Apr; 26 (12): 1437-1444
(check this in PDF content)
12
Ficheux A, Gayrard N, Szwarc I, Andress D, Soullier S, Duny Y, Goubert G, Thomas M, Bismuth-Mondolfo J, Daurès JP, Brunet P, Servel MF, Argilés A. The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis. Nephrol Dial Transplant 2011; 26 (7): 2281-2289
(check this in PDF content)
13
Hayashi K, Fukumura H, Yoshikava S, et al. Kobunshi Robunshu. Chem Abstrs 1987; 44 (12): 917–924
(check this in PDF content)
14
Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med 2013; 4 (1): 611–616
(check this in PDF content)
15
Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med 2011; (2): 205–112
(check this in PDF content)
16
Heidari B. The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. Caspian J Intern Med 2012; (3): 428–435
(check this in PDF content)
17
Heidari B. Undifferentiated arthritis: predictive factors of persistent arthritis and treatment decisions. Caspian J Intern Med 2010; (1): 79–88
(check this in PDF content)
18
Knezevic MZ, Djordjevic VV, Radovanovic-Velickovic RM, Stankovic JJ, Cvetkovic TP, Djordjevic VM. Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients. Ren Fail 2012; 34 (7): 849-855
(check this in PDF content)
19
Lee KS, van Holsbeeck MT, Abbud A. Atypical rapid progression of osteoarticular amyloidosis involving the hip in a patient on hemodialysis usingpolyacrylonitrile membranes. Biomaterials 2008; 29 (9): 1139-1146
(check this in PDF content)
20
Liu TY, Lin WC, Huang LY, Chen SY, Yang MC. Hemocompatibility and anaphylatoxin formation of protein-immobilizing polyacrylonitrile hemodialysis membrane. Skeletal Radiol 2010; 39 (1): 79–83
(check this in PDF content)
21
Martello M, Di Luca M. Acetate-free biofiltration. G Ital Nefrol 2012; 29 [Suppl 55]: 62–71
(check this in PDF content)
22
Matsuda K, Moriguchi T, Harii N, Yanagisawa M, Harada D, Sugawara H. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure. Contrib Nephrol 2011; (173): 182-190
(check this in PDF content)
23
Nakano A. Ethylene vinyl alcohol co-polymer as a highperformance membrane: an EVOH membrane with excellentbiocompatibility. Contrib Nephrol 2011; (173): 164–167
(check this in PDF content)
24
Nasr R, Saifan C, Barakat I, Azzi YA, Naboush A, Saad M, Sayegh SE. Relationship between platelet count and hemodialysis membranes. Int J Nephrol Renovasc Dis 2013; 14 (6): 143–147
(check this in PDF content)
25
Nusair MB, Rajpurohit N, Alpert MA. Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease. Cardiorenal Med 2012; (2): 117–124
(check this in PDF content)
26
Olafiranye F, Kyaw W, Olafiranye O. Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report. Case Rep Med 2011; 20 (11): 134–145
(check this in PDF content)
27
Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GF. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database Syst Rev 2012; 12 (9): CD005016 pub 2
(check this in PDF content)
28
Panichi V, Rizza GM, Paoletti S, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008; 17 (23): 2337–2343.
(check this in PDF content)
29
Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol 2012; 35 (6): 559–572
(check this in PDF content)
30
Poon PY, Szeto CC, Kwan BC, et al. Relationship between serum levels of tumour necrosis factor-related apoptosis-inducing ligand and the survival of Chinese peritoneal dialysis patients. Nephrology (Carlton) 2012; 25 (17): 466–471
(check this in PDF content)
31
Post JB. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis 2010; 55 (6): 25–28
(check this in PDF content)
32
Puchades MJ, Saez G, Muñoz MC, Gonzalez M, Torregrosa I, Juan I, Miguel A. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 2013; 80 (9): 177–186
(check this in PDF content)
33
Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Semin Dial 2006; 28 (19): 129–135
(check this in PDF content)
34
Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 4 (98): 731–733
(check this in PDF content)
35
Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; (344): 1959–1965
(check this in PDF content)
36
Sakai Y. Polymethylmethacrylate membrane with a series of serendipity. Contrib Nephrol 2011; (173): 137-147
(check this in PDF content)
37
Sawires HK, Mohamed WA, Schaalan MF. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure. Iran J Kidney Dis 2012; 6 (5): 366–372
(check this in PDF content)
38
Scand J. Traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Urol Nephrol. 2004; (38): 405–416
(check this in PDF content)
39
Senthilkumar S, Rajesh S, Jayalakshmi A, Mohan D. Biocompatibility studies of polyacrylonitrile membranes modified with carboxylatedpolyetherimide. Mater Sci Eng C Mater Biol Appl 2013; 33 (7): 3615–3626
(check this in PDF content)
40
Shtilman MI. Immobilzation on polymer. VSP. Utrecht – Tpkyo., 1993; 3–496
(check this in PDF content)
41
Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J 2013; 3 (12): 320–327
(check this in PDF content)
42
Sniderman AD, Solhpour A, AlamA , Williams K, Sloand JA. Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clin J Am Soc Nephrol 2010; (5): 335–340
(check this in PDF content)
43
Stanković-Popović V, Popović D, Dimković N, Maksić D, Vasilijić S, Colić M, Vucinić Z, Radjen S, Milicić B. Influence of peritoneal dialysis solution biocompatibility on long-term survival of patients on continuous ambulatory peritoneal dialysis and the technique itself. Vojnosanit Pregl 2013; 70 (4): 352– 362
(check this in PDF content)
44
Taylor SP, Taylor BT. Healthcare-associated pneumonia in hemodialysis patients: Clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy. Respirology 2012; 5 (12): 243–250
(check this in PDF content)
45
Urbani A, Lupisella S, Sirolli V, Bucci S, Amoroso L, Pavone B, Pieroni L, Sacchetta P, Bonomini M. Proteomic analysis of protein adsorption capacity of different haemodialysis membranes. Mol Biosyst 2012; 8 (4): 1029–1039
(check this in PDF content)
46
Williams D. The role of nitric oxide in biocompatibility. Med Device Technol 2008; 19 (7): 8–10
(check this in PDF content)
47
Yoo HH, Martin LC, Kochi AC, et al. Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension? BMC Nephrol 2012; (13): 80–85
(check this in PDF content)
48
Басов НИ, Земсков ВН. Комплемент и его роль в регуляции иммунологических реакций. Успехи соврем биол 1982; (24): 51–58
(check this in PDF content)
49
Валуев ЛИ. Итоги науки и техники [Химия и технология высокомолекулярных соединений. Т. 16], pед. Н.А. Платэ, ВИНИТИ, М., 1976; 3–210
(check this in PDF content)
50
Васильев АН, Губарь НЯ, Смирнов АВ, Суглобова ЕД. Опыт применения предилюционной онлайн гемодиафильтрации у больных с терминальной почечной недостаточностью. Нефрология 2008; 4 (12): 18–25
(check this in PDF content)
51
Даугирдас ДТ, Блейк ПД, Инг ТС. Руководство по диализу. 3-е изд., Триада, Тверь, 2003; 6–386
(check this in PDF content)
52
Жозефович М, Жозефонвич ЖЖ. Полимерные материалы. Всес Химич Общ 1985; 30 (4): 410–419
(check this in PDF content)
53
Зорчева РИ, Икономов ВХ, Паскалев ДН. Онлайн гемодиафильтрация и удаление фосфатов у больных с терминальной почечной недостаточностью, получающих лечение гемодиализом. Нефрология 2013; 1 (17): 9–14
(check this in PDF content)
54
Зубаиров ДМ. Биохимия свертывания крови. Медицина, М., 1978; 3–58
(check this in PDF content)
55
Казарян ПА, Баблоян АС, Егиазарян КВ. Мембранные аспекты патогенеза терминальной почечной недостаточности. Нефрология 2008; 4 (12): 26–31
(check this in PDF content)
56
Килстейн ЯТ, Флизер Д. Продленный ежедневный диализ. Нефрология 2008; 2 (12): 5–15
(check this in PDF content)
57
Кузнецов АЮ, Петров АК, Макрянский ВА. Синтетические полимеры медицинского назначения. Тез Всес симпоз. 1989; (1): 103–104
(check this in PDF content)
58
Перепечко ИИ. Введение в физику полимеров. Химия, М., 1978; 5–312
(check this in PDF content)
59
Полухина ЕВ, Москаленко НВ, Канин ЕС и др. Случай выраженной метастатической кальцификации периаортикулярных тканей у пациента на хроническом гемодиализе. Нефрология 2013; 4 (17): 23–27
(check this in PDF content)
60
Разъяснение для использования территориальными органами ФАС России при определении товарных границ рынка медицинского оборудования и рынка расходных материалов для гемодиализа, 2009 г.
(check this in PDF content)
61
Севастьянов ВИ, Ласкина ОВ, Новикова СП, и др. Современные гемосовместимые материалы для сердечнососудистой хирургии. В: Шумаков ВИ, ред. ВНИИМИ, М., 1987; 3–73
(check this in PDF content)
62
Севастьянов ВИ. Биоматериалы медицинского назначения. Трансплантология и искусственные органы. Тезисы докладов I Всероссийского съезда по трансплантологии и искусственным органам (Москва, 8–10 октября 1998 г.). М., 1998; 100
(check this in PDF content)
63
Севастьянов ВИ. Биосовместимость. Медицина, М., 1999; 4–368
(check this in PDF content)
64
Смурова ЕВ, Доброва НВ. Итоги науки и техники (Серия: Химия и технология высокомолекулярных соединений). ВИНИТИ, М., 1976; 3–60
(check this in PDF content)
65
Уорд АМ, Уичер ДжТ. Иммунохимия в клинической лабораторной практике. Медицина, М., 1981; 3–236
(check this in PDF content)
66
Штильман МИ. Полимеры медико-биологического назначения. ИКЦ Академкнига, М., 2006; 5–400
(check this in PDF content)
67
Шумаков ВИ. Искусственные органы. Медицина, М., 1990; 4–80
(check this in PDF content)
68
Яковенко АА, Яковлев ВД, Асанина ЮЮ, Кучер АГ. Роль хронического воспаления в патогенезе «уремической недостаточности питания» у пациентов с терминальной почечной недостаточностью, получающих лечение хроническим гемодиализом. Нефрология 2009; 1 (13): 20–24
(check this in PDF content)